Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRB1 | P18505 | 1/20 | 0.49 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.49 |
| ▸ | CTSS | P25774 | 2/20 | 0.47 |
| ▸ | CTSK | P43235 | 2/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | UTS2R | Q9UKP6 | 7/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | GPR88 | Q9GZN0 | 2/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ACACB | O00763 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5676217 | 0.86 | GABRB1 (0.52) | GABRB1GABRB2CTSSCTSKCTSB | |
| SCHEMBL5848532 | 0.86 | GABRB1 (0.52) | GABRB1GABRB2CTSSCTSKCTSB | |
| SCHEMBL29465735 | 0.84 | CTSK (0.52) | GABRB1GABRB2CTSSCTSKCTSB | |
| SCHEMBL5460811 | 0.84 | CTSK (0.52) | GABRB1GABRB2CTSSCTSKCTSB | |
| SCHEMBL717324 | 0.84 | CTSK (0.52) | GABRB1GABRB2CTSSCTSKCTSB | |
| SCHEMBL1784108 | 0.84 | CTSK (0.52) | GABRB1GABRB2CTSSCTSKCTSB | |
| SCHEMBL13802924 | 0.84 | GABRB1 (0.53) | GABRB1GABRB2CTSSCTSKCTSB | |
| SCHEMBL9295219 | 0.84 | GABRB1 (0.50) | GABRB1GABRB2CTSSCTSKCTSB | |
| SCHEMBL21507528 | 0.83 | CTSK (0.46) | CTSSCTSKMAPTMEN1KMT2A | |
| SCHEMBL8362256 | 0.83 | GABRB1 (0.52) | GABRB1GABRB2CTSSCTSKCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0337714-A2 | HIV protease inhibitors useful for the treatment of aids | MERCK & CO. INC. (US) | 1989-10-18 | — | — | EP | disclosed |